Orexo Loses Bid For New Trial Over Teva's Suboxone Generic
A Delaware federal judge won't give Orexo AB another chance to prove that a Teva unit's generic version of the opioid addiction treatment drug Suboxone infringes a patent covering its own...To view the full article, register now.
Already a subscriber? Click here to view full article